Abstract
Recently two germline mutations in the oligomerization domain of p53 have been identified in patients with Li–Fraumeni and Li–Fraumeni-like Syndromes. We have used biophysical and biochemical methods to characterize these two mutants in order to better understand their functional defects and the role of the p53 oligomerization domain (residues 325–355) in oncogenesis. We find that residues 310–360 of the L344P mutant are monomeric, apparently unfolded and cannot interact with wild-type (WT) p53. The full length L344P protein is unable to bind sequence specifically to DNA and is therefore an inactive, but not a dominant negative mutant. R337C, on the other hand, can form dimers and tetramers, can hetero-oligomerize with WTp53 and can bind to a p53 consensus element. However, the thermal stability of R337C is much lower than that of WTp53 and at physiological temperatures more than half of this mutant is less than tetrameric. Thus, the R337C mutant retains some functional activity yet leads to a predisposition to cancer, suggesting that even partial inactivation of p53 oligomerization is sufficient for accelerated tumour progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davison, T., Yin, P., Nie, E. et al. Characterization of the oligomerization defects of two p53 mutants found in families with Li–Fraumeni and Li–Fraumeni-like syndrome. Oncogene 17, 651–656 (1998). https://doi.org/10.1038/sj.onc.1202062
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202062
Keywords
This article is cited by
-
The multiple mechanisms that regulate p53 activity and cell fate
Nature Reviews Molecular Cell Biology (2019)
-
Heterozygous p53V172F mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53
Oncogene (2016)
-
Tris-acetate polyacrylamide gradient gel electrophoresis for the analysis of protein oligomerization
Analytical and Bioanalytical Chemistry (2016)
-
ArhGAP30 promotes p53 acetylation and function in colorectal cancer
Nature Communications (2014)
-
Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
Tumor Biology (2013)